Research News and Research

RSS

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute.

6 Jun 2006

Vitamin K in the U.S. diet

Much of what is known about the content of vitamin K in the US food supply comes from research conducted in the Vitamin K Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.

6 Jun 2006

PET imaging of cerebral cannabinoid CB1 receptors with [11C]JHU75528

A team of Johns Hopkins researchers developed a new radiotracer - a radioactive substance that can be traced in the body - to visualize and quantify the brain's cannabinoid receptors by positron emission tomography (PET).

6 Jun 2006

Calpain protein key to preventing or promoting cell death

A protein called calpain can be the key either preventing or promoting the cell death, a Queen's University study has found.

6 Jun 2006

Study results may aid battle against insect-borne diseases

Scientists studying the widespread symbiotic bacteria Wolbachia have long been interested in its ability to proliferate.

6 Jun 2006

Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration

Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults and a person's risk may partly depend upon diet.

6 Jun 2006

Better understanding of DNA damage

Researchers have known for years that damaged DNA can lead to human diseases such as cancer, but how damage occurs - and what causes it - has remained less clear.

6 Jun 2006

New procedures to help decide which breast cancer patients will benefit most from radiotherapy

New procedures which will help doctors decide which breast cancer patients will benefit most from radiotherapy begin trials this week.

6 Jun 2006

Novel research points to promising relief target for chronic pain

By some accounts, chronic pain affects nearly 100 million Americans from such varied causes as arthritis, sciatica, cancer, diabetes. Most forms of pain result from identifiable causes which serve the "good" purpose in warning of a real physical problem that needs attention, or rest.

6 Jun 2006

Factors influencing the route of administration for Epoetin treatment among hemodialysis patients in the U.S.

A forthcoming article to be published in the July 2006 issue of the American Journal of Kidney Diseases finds that physician decision-making for the delivery of epoetin therapy is primarily influenced by the type of ownership and financial incentives associated with dialysis centers.

6 Jun 2006

Researchers show that different forms of amyloid beta lead to neural damage in different ways

Researchers at UC Irvine have shown that different forms of amyloid beta lead to neural damage in different ways, leading to an increasingly complex view of amyloid toxicity in the Alzheimer brain.

6 Jun 2006

Researchers discover the presence of the genetic material RNA in the centrosome

Researchers have discovered the presence of the genetic material RNA in the centrosome, the organizing structure inside each cell that assures proper cell division.

6 Jun 2006

New research on brain, hormones and behavior

New clinical and basic science research findings focusing on the interaction between hormones and the brain and its influence on behavior will be presented for the first time at the 6th International Congress of Neuroendocrinology.

6 Jun 2006

Maternal vitamin D levels and infant bone density

Can bones remember? According to new research presented at the IOF World Congress on Osteoporosis in Toronto, Canada they can.

6 Jun 2006

Bill Gates puts his money where his mouth is again

Once again Microsoft founder Bill Gates is putting his money where his mouth is and the world's poorest women will benefit.

6 Jun 2006

Type 1 diabetes results from selective destruction of pancreatic islet beta cells

IDDM, which used to be referred to as Type 1 diabetes, results from selective destruction of insulin-producing pancreatic islet beta cells by the body's immune system.

6 Jun 2006

Gene therapy used to accelerate muscle regeneration

Researchers have successfully used gene therapy to accelerate muscle regeneration in experimental animals with muscle damage.

6 Jun 2006

New drug combo to cut cardiovascular disease

A major international study to test whether a new combination treatment that increases good "HDL" cholesterol prevents heart attacks and strokes will start to recruit patients later this year.

6 Jun 2006

Potential new treatment for diabetic nerve damage

A potentially ground-breaking treatment for nerve damage caused by diabetes has shown promising results in preclinical and early patient trials.

From The University of Manchester 6 Jun 2006

Knowledge helps prevent spread of herpes virus

A new study suggests that the risk of transmitting the virus that causes most cases of genital herpes could be cut in half by more testing and informing sexual partners of infection.

6 Jun 2006